» Articles » PMID: 33772623

Association Between Genetic Variations in Carbamoyl-phosphate Synthetase Gene and Persistent Neonatal Pulmonary Hypertension

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2021 Mar 27
PMID 33772623
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent pulmonary hypertension of the new-borns (PPHN) is one of the main etiologies of morbidity as well as mortality in neonates. Previous studies found that genetic polymorphisms in urea cycle enzymes are associated with PPHN. Few of the genetic polymorphisms in neonates have been recognized with PPHN. We aimed to find out the prevalence of the CPS-I gene polymorphism and to correlate the genotype with the serum nitric oxide (NO) levels in Egyptian neonates with idiopathic PPHN. We included neonates diagnosed with PPH (n = 150) while the control group included healthy neonates with matched age and sex (n = 100). The CPS-I gene polymorphism: A/C, trans-version substitution, rs4399666 genotype was identified using TaqMan-based quantitative PCR. The results revealed that the CPS-I A/C rs4399666 gene polymorphism and lower serum NO levels were significantly associated with idiopathic PPHN in neonates. In addition, serum NO level was significantly associated with an rs4366999 A/C variant gene in idiopathic PPHN (p = 0.001). Univariable regression analysis demonstrated that there was a significant association between CPS-I A/C rs4399666 CC and increased risk of PPHN (odd ratio, 95% CI of 1.8 (0.78 to 1.75), p-value = 0.04).Conclusion: We concluded that mutant CPS-I A/C rs4399666 minor variant especially the homozygous CC genotype is frequently distributed among the PPHN group. This demonstrates that the presence of mutant CPS-I rs4399666 does not necessarily predispose to the development of PPHN in neonates, but nonetheless, if the C allele is inherited in the homozygous CC genotype, it is associated with a higher risk of PPHN. What is Known: • Prior studies found that polymorphisms in urea cycle enzyme genes are associated with PPHN. • Association between CPS-1 gene polymorphisms is significantly associated with PPHN. What is New: • The prevalence of CPS-1, A/C trans-version substitution, rs4399666 gene polymorphism in Egyptian neonates presented with idiopathic PPHN. • Mutant CPS-I A/C rs4399666 especially the homozygous CC genotype is more frequently distributed among PPHN, and it is significantly associated with low serum nitric oxide level.

Citing Articles

Arginine metabolism is a biomarker of red blood cell and human aging.

Reisz J, Earley E, Nemkov T, Key A, Stephenson D, Keele G Aging Cell. 2024; 24(2):e14388.

PMID: 39478346 PMC: 11822668. DOI: 10.1111/acel.14388.


Genome-wide association study identifies WWC2 as a possible locus associated with persistent pulmonary hypertension of the newborn in the Thai population.

Nakwan N, Kunhapan P, Chaiyasung T, Satproedprai N, Singkhamanan K, Mahasirimongkol S Transl Pediatr. 2023; 12(1):1-12.

PMID: 36798934 PMC: 9926135. DOI: 10.21037/tp-22-280.


A nomogram prediction model for early death in patients with persistent pulmonary hypertension of the newborn.

Lin C, Mi J, Zhang Y, Duan S, Wu J, Li Y Front Cardiovasc Med. 2023; 9:1077339.

PMID: 36620618 PMC: 9813219. DOI: 10.3389/fcvm.2022.1077339.


Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Christou H, Khalil R Am J Physiol Heart Circ Physiol. 2022; 322(5):H702-H724.

PMID: 35213243 PMC: 8977136. DOI: 10.1152/ajpheart.00021.2022.

References
1.
Abman S . Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology. 2007; 91(4):283-90. DOI: 10.1159/000101343. View

2.
Abman S, Hansmann G, Archer S, Ivy D, Adatia I, Chung W . Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015; 132(21):2037-99. DOI: 10.1161/CIR.0000000000000329. View

3.
Tyson J, Wright L, Bauer C, KORONES S, Stevenson D, Verter J . Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000; 105(1 Pt 1):14-20. DOI: 10.1542/peds.105.1.14. View

4.
Steurer M, Jelliffe-Pawlowski L, Baer R, Partridge J, Rogers E, Keller R . Persistent Pulmonary Hypertension of the Newborn in Late Preterm and Term Infants in California. Pediatrics. 2016; 139(1). DOI: 10.1542/peds.2016-1165. View

5.
Lai M, Chu S, Lakshminrusimha S, Lin H . Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Pediatr Neonatol. 2017; 59(1):15-23. DOI: 10.1016/j.pedneo.2016.09.011. View